Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 11

1.

Fine-needle aspiration and core biopsy in the diagnosis of breast lesions: A comparison and review of the literature.

Mitra S, Dey P.

Cytojournal. 2016 Aug 31;13:18. doi: 10.4103/1742-6413.189637. Review.

2.

Mammographic density and inter-observer variability of pathologic evaluation of core biopsies among women with mammographic abnormalities.

Trocchi P, Ursin G, Kuss O, Ruschke K, Schmidt-Pokrzywniak A, Holzhausen HJ, Löning T, Thomssen C, Böcker W, Kluttig A, Stang A.

BMC Cancer. 2012 Nov 24;12:554. doi: 10.1186/1471-2407-12-554.

4.
5.

Reliability and validity of needle biopsy evaluation of breast-abnormalities using the B-categorization--design and objectives of the Diagnosis Optimisation Study (DIOS).

Kluttig A, Trocchi P, Heinig A, Holzhausen HJ, Taege C, Hauptmann S, Boecker W, Decker T, Loening T, Schmidt-Pokrzywniak A, Thomssen C, Lantzsch T, Buchmann J, Stang A.

BMC Cancer. 2007 Jun 14;7:100.

6.
7.
8.

Cost-effectiveness of stereotactic large-core needle biopsy for nonpalpable breast lesions compared to open-breast biopsy.

Groenewoud JH, Pijnappel RM, van den Akker-Van Marle ME, Birnie E, Buijs-van der Woude T, Mali WP, de Koning HJ, Buskens E.

Br J Cancer. 2004 Jan 26;90(2):383-92.

9.
10.

Conversion to core biopsy in preoperative diagnosis of breast lesions: is it justified by results?

Shannon J, Douglas-Jones AG, Dallimore NS.

J Clin Pathol. 2001 Oct;54(10):762-5.

11.

Waiting times from abnormal breast screen to diagnosis in 7 Canadian provinces.

Olivotto IA, Bancej C, Goel V, Snider J, McAuley RG, Irvine B, Kan L, Mirsky D, Sabine MJ, McGilly R, Caines JS.

CMAJ. 2001 Aug 7;165(3):277-83.

Supplemental Content

Support Center